Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $13.6700 (2.01%) ($13.4000 - $14.1300) on Fri. Jul. 17, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.78% (three month average) | RSI | 55 | Latest Price | $13.6700(2.01%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -1.5% a day on average for past five trading days. | Weekly Trend | ATRA declines -3% a week on average for past two weeks. | Market Behavior | Normal for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(53%) ARKG(45%) IBB(45%) IWO(44%) ARKK(43%) | Factors Impacting ATRA price | ATRA will decline at least -3.39% in a week (0% probabilities). VIXM(-32%) VXX(-26%) XLC(-10%) UNG(-9%) UUP(-8%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.39% (StdDev 6.78%) | Hourly BBV | 0 () | Intraday Trend | 2% | | | |
|
Resistance Level | $13.92 | 5 Day Moving Average | $13.61(0.44%) | 10 Day Moving Average | $14.39(-5%) | 20 Day Moving Average | $13.92(-1.8%) | To recent high | -11.8% | To recent low | 72.6% | Market Cap | $1.016b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |